Regina M. Paglia Dicerna Pharmaceuticals Inc (DRNA) insider trading activity

Regina M. Paglia is Chief Human Resources Officer of Dicerna Pharmaceuticals Inc. Currently has a direct ownership of 2,027 shares of DRNA, which is worth approximately $77,492. The most recent transaction as insider was on Jul 06, 2021, when has been sold 1,404 shares (Common Stock) at a price of $37.05 per share, resulting in proceeds of $52,018. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.03K

0% 3M change

0% 12M change

Total Value Held $77,492

Regina M. Paglia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 06 2021	SELL Payment of exercise price or tax liability	$52,018 $37.05 p/Share	1,404 Reduced 40.92%	2,027 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	-	3,162 Added 47.96%	3,431 Common Stock
Jun 25 2021	SELL Open market or private sale	$38,000 $38.0 p/Share	1,000 Reduced 78.8%	269 Common Stock
Jun 25 2021	BUY Exercise of conversion of derivative security	$22,580 $22.58 p/Share	1,000 Added 44.07%	1,269 Common Stock
Jun 22 2021	SELL Open market or private sale	$680,252 $36.9 p/Share	18,435 Reduced 98.56%	269 Common Stock
Jun 22 2021	BUY Exercise of conversion of derivative security	$365,935 $19.85 p/Share	18,435 Added 49.64%	18,704 Common Stock
Jun 17 2021	SELL Open market or private sale	$310,085 $35.79 p/Share	8,664 Reduced 96.99%	269 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$160,197 $18.49 p/Share	8,664 Added 49.24%	8,933 Common Stock
Jun 16 2021	SELL Open market or private sale	$1,132,832 $35.89 p/Share	31,564 Reduced 99.15%	269 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$653,690 $20.71 p/Share	31,564 Added 49.79%	31,833 Common Stock
Jun 15 2021	SELL Payment of exercise price or tax liability	$4,003 $35.74 p/Share	112 Reduced 29.4%	269 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	-	381 Added 50.0%	381 Common Stock
Jun 01 2021	SELL Open market or private sale	$139,222 $31.42 p/Share	4,431 Reduced 100.0%	0 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 50.0%	4,431 Common Stock
May 03 2021	SELL Open market or private sale	$136,076 $30.71 p/Share	4,431 Reduced 100.0%	0 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 50.0%	4,431 Common Stock
Apr 01 2021	SELL Open market or private sale	$114,586 $25.86 p/Share	4,431 Reduced 100.0%	0 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 50.0%	4,431 Common Stock
Mar 01 2021	SELL Open market or private sale	$129,385 $29.2 p/Share	4,431 Reduced 100.0%	0 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 50.0%	4,431 Common Stock
Feb 02 2021	SELL Open market or private sale	$106,344 $24.0 p/Share	4,431 Reduced 100.0%	0 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 50.0%	4,431 Common Stock
Jan 25 2021	SELL Open market or private sale	$158,150 $25.0 p/Share	6,326 Reduced 100.0%	0 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$57,293 $12.93 p/Share	4,431 Added 41.19%	6,326 Common Stock
Jan 08 2021	SELL Payment of exercise price or tax liability	$23,406 $23.29 p/Share	1,005 Reduced 34.66%	1,895 Common Stock

RMP

Regina M. Paglia

Chief Human Resources Officer

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Dicerna Pharmaceuticals Inc insider buys or sells DRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dicerna Pharmaceuticals Inc

Track Activities on DRNA

Account